PMN ▼ -2.7% - ProMIS Neurosciences, Inc. $PMN - ProMIS Neurosciences Licenses Next-Generation TXP1 Brain-Selective Shuttling Technology from Ossianix to Expand PMN310 Franchise and Pipeline 17-NOV-2026 02:30 AM ET